Patents
Patents for C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132)
01/2009
01/15/2009US20090018116 Therapeutic Compounds
01/15/2009US20090018054 Cholesteryl Ester Transfer Protein Inhibitors
01/14/2009EP2014285A1 NPYY5 antagonists
01/13/2009US7476699 Cosmteic composition sensitive to heat, light and/or oxygen stabilized with an aqueous nanopigment suspension of a 1-(o-hydroxyphenyl)-3-o- or p-(alkanoylamino)-5-(optional alkoxy)phenyl-1,3,5-triazine with a mean particle size of 100-400 nm
01/13/2009US7476675 Quinolinone derivatives and uses thereof
01/13/2009US7476672 Acetylenic compounds useful in treating inflammatory disorders
01/08/2009WO2009006243A2 Processes for preparing bicyclic oxazine carboxaldehyde and beta-lactamase inhibitors
01/08/2009WO2009005076A1 Amide compound
01/08/2009WO2009004430A1 N-benzyl oxazolidinones and related heterocycleic compounds as potentiators of glutamate receptors
01/08/2009WO2008119457A3 Lactam-substituted dicarboxylic acids and use thereof
01/08/2009US20090012289 by reacting with optically active D-mandelic acid, removing the salt formation; purification; use as intermediate for the synthesis of fungicides and medicaments
01/08/2009US20090012074 Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to modulation of the Dopamine D3 receptor
01/08/2009US20090012055 Piperidine derivatives such as 4-{4-[3-(2-Methoxybenzyloxy)propoxy]phenyl}-3-[3-methoxy-5-(3-methoxypropoxy)benzyloxy]piperidine, suitable as renin inhibitors, used for the treatment of hypertension, heart failure, glaucoma, cardiac infarction, kidney failure or restenosis; improved pharmacokinetics
01/08/2009US20090012010 Amino acid derivatives as calcium channel blockers
01/08/2009CA2692265A1 Amide compounds
01/07/2009EP2010488A2 Renin inhibitors
01/07/2009EP1569916B1 Substituted aralkyl derivatives
01/01/2009US20090004653 Sulfonated [8,9]benzophenoxazine dyes and the use of their labelled conjugates
12/2008
12/31/2008WO2009001817A1 COMPOUND HAVING 11β-HSD1 INHIBITORY ACTIVITY
12/31/2008WO2009001203A2 An improved process for the preparation of aprepitant
12/31/2008EP2007743A2 Methods for synthesizing ammonia borane
12/31/2008EP2007742A1 Process for producing 3-[4-(1,1-dimethyl-propyl)-phenyl]-2-methyl-propionaldehyde and cis-4-{3-[4-(1,1-dimethyl-propyl)-phenyl]-2-methyl-propyl}-2,6-dimethyl-morpholine (amorolfine)
12/31/2008EP2007741A1 Enantiomerically pure s-etifoxine, pharmaceutical compositions thereof and methods of their use
12/31/2008EP2007705A1 Nitric oxide enhancing prostaglandin compounds, compositions and methods of use
12/31/2008EP1435785B1 Iminobenzoxazines, iminobenzothiazines and iminoquinazolines for controlling invertebrate pests
12/25/2008US20080318957 Polybasic bacterial efflux pump inhibitors and therapeutic uses thereof
12/25/2008US20080318956 Inflammatory cytokine release inhibitor
12/25/2008US20080318941 4' substituted compounds having 5-ht6 receptor affinity
12/25/2008US20080317806 Antiparasitic Compounds
12/24/2008WO2008156443A1 Benzoxazine containing compositions of matter and curable compositions made therewith
12/24/2008WO2008076754A3 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
12/24/2008WO2007117653A3 Cdk9-pi3k-akt inhibitors for cancer treatment
12/24/2008CN100445272C Non-steroidal (hetero) cyclically substd. acylanilides with mixed gestagen and androgen activity
12/18/2008WO2008153182A1 Morpholine derivative
12/18/2008WO2008130616A3 Diaryl morpholines as cb1 modulators
12/18/2008WO2008130319A3 Novel n-tetrahydronaphtalene or n-chromane carboxamide derivatives for the treatment of pain
12/18/2008WO2008079339A3 Tetracycline derivatives for the treatment of bacterial, viral and parasitic infections
12/18/2008US20080312237 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
12/18/2008US20080312236 3-Heteroaryl-3-Hydroxy-2-Amino-Propyl Amines And Related Compounds Having Analgesic And/Or Immuno Stimlant Activity
12/18/2008CA2690348A1 Morpholine derivative
12/17/2008EP1773763B1 Lysine based compounds
12/17/2008EP1278803B1 Sulfonated ¬8,9 benzophenoxazine dyes and the use of their labelled conjugates
12/17/2008EP1255742B1 2-thio-4h-3,1-benzoxazin-4-one derivatives for use as enzyme inhibitors
12/17/2008CN101326169A Glucocorticoid receptor modulators as antiinflammatory agents
12/17/2008CN100443480C Tricyclic compound and its preparation and use
12/17/2008CN100443478C Preparation method of two kinds of pure optical isomerism serine morpholine dione
12/16/2008US7465814 Sulfonate compound and fluorescent probe using the same
12/11/2008WO2008149380A2 A process for solvent-less synthesis of benzoxazine (bz)
12/11/2008WO2008073138A3 Terephthalamate compounds and compositions, and their use as hiv integrase inhibitors
12/11/2008WO2008034039A3 Novel tetrahydro-isoquinolines
12/11/2008US20080306258 Cyclopropane compounds and pharmaceutical use thereof
12/11/2008US20080306072 Organic Compounds
12/11/2008US20080306054 Pharmaceutical Compounds
12/11/2008US20080305051 Menthane Carboxamide Derivatives Having Cooling Properties
12/10/2008CN101321730A Cyclopropyl amines as modulators of the histamine H3 receptor
12/10/2008CN100441574C Tricyclic compounds, their production and use
12/09/2008US7462714 Produced by reacting a dimethyl 3-oxoglutarate with malononitrile in methanol in presence of morpholine to form an intermediate, reacting intermediate with sulfur, heating and isolating 5-amino-3-carboxymethyl-4-cyano-2-thiophene caroxylic acid; bone diseases
12/09/2008US7462628 Preventives/remedies for urinary disturbance
12/09/2008US7462608 Non nucleoside reverse transcriptase inhibitors
12/04/2008WO2008145526A1 Benzoxazine-formulations with reduced outgassing behaviour
12/04/2008WO2007146122A3 Tetrahydropyrido[3,4-d]pyrimidines and related analogues
12/03/2008EP1996563A1 Heterobicyclic sulfonamide derivatives for the treatment of diabetes
12/03/2008CN101316827A Heterocyclic amide derivatives as RXR agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes
12/03/2008CN101316585A Process for the stereoselective preparation of (-)-halofenate and intermediates thereof
12/02/2008US7459580 Process for trans-4-amino-1-cyclohexanecarboxilic acid derivatives
12/02/2008US7459555 2H-naphtho(1,2-b) pyrans photochromatic dyes useful in synthetic resin material (ophthalmic lens)
12/02/2008US7459414 Herbicides
12/02/2008CA2361841C Mevinolin derivatives
12/02/2008CA2305548C Prostaglandin agonists and their use to treat bone disorders
11/2008
11/27/2008WO2007136790A3 Intracellular kinase inhibitors
11/27/2008WO2005025498A3 Substituted acetanilides and benzamides for the treatment of asthma and pulmonary inflammation
11/27/2008US20080293721 Arylthioacetamide carboxylate derivatives as fkbp inhibitors for the treatment of neurological diseases
11/27/2008US20080293709 Novel 2-Amino-Heterocycles Useful in the Treatment of Abeta-Related Pathologies
11/27/2008US20080293094 Novel Enzymatic Substrates Derived from Phenoxazinone and Their Use as Developer in Detection of Microorganisms with Peptidase Activity
11/27/2008DE102007023614A1 New amide compounds used for treatment of gynecological diseases e.g. endometriosis, for female fertility control and female hormone replacement therapy, has general formula
11/26/2008EP1994005A1 Tetrahydronaphthaline derivatives, methods for the production and use thereof as anti-inflammatory agents
11/26/2008EP1421070B1 New piperidinyl derivates as modulators of chemokine receptor activity
11/26/2008CN101312942A Aldimines comprising reactive groups containing active hydrogen, and use thereof
11/20/2008WO2008140859A1 Deuterated venlafaxines and 0-desmetylvenlafaxines with serotoninergic and / or norepinephrinergic activity
11/20/2008WO2008119685A3 Oxazolidine and morpholine carboxamide derivatives as p2x7 modulators
11/20/2008WO2008109463A3 Red-shifted luciferase
11/20/2008US20080286820 Novel phenoxazinone derivatives as enzyme substrates and use thereof as indicator in the detection of microorganisms with peptidase activity
11/20/2008CA2680912A1 Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity
11/19/2008EP1992629A1 Preparation of levofloxacin and forms thereof
11/19/2008EP1991643A2 Use of polynuclear phenolic compounds as stabilisers
11/19/2008EP1991534A1 Process for the preparation of 2-(4-hydroxy-3-morfolynil)-2-cyclohexenone
11/19/2008CN101309913A Process for the preparation of delmopinol and derivatives thereof
11/18/2008US7452992 Heterocyclic compounds as CCR5 antagonists
11/18/2008US7452878 Biaromatic compounds which activate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereof
11/18/2008CA2221517C Synthesis of n-substituted oligomers
11/13/2008US20080281096 Kinetic dynamic resolution; mixing a sample containing enantiomorphs in solvent; heating; crystallization; isolation of crystals
11/13/2008US20080280898 5-Bromo-1'-[(3-methyl-1H-inden-2-yl)carbonyl]spiro[indole-3,4'-piperidin]-2(1H); vasopressin receptor antagonist; antidepressant, anxiolytic agent; dysmenorrhea, hypertension, chronic heart failure, inappropriate secretion of vasopressin, liver cirrhosis, nephrotic syndrome, obsessive compulsive disorder
11/13/2008US20080280895 5-Amino-4-Hydroxy-7-(1H-Indolmethyl)-8-Methylnonamide Derivatives as Renin Inhibitors for the Treatment of Hypertension
11/13/2008US20080280883 Muscarinic Receptor Antagonists
11/12/2008EP1844029B1 Novel heterocyclic oxime derivatives, method for preparing same and use thereof as hypoglycaemic or hypolipidemic agents
11/12/2008EP1534291B1 2-(phenylthiomethyl)- morpholine derivatives for use as selective norepinephrine reuptake inhibitors
11/12/2008CN100432060C Process for producing benzoxazine derivative and production intermediate thereof
11/06/2008WO2008133273A1 Pharmaceutical composition for treatment of alzheimer's disease
11/06/2008US20080275003 Phospholipase inhibitor; prevention or therapy of microbial infection; bactericides; fungicides; viricides; parasiticides; using quaternary or phosphonium group containing compounds
11/06/2008US20080274492 Detection of platinum group metals with fluorophores via allylic oxidative insertion
1 ... 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... 112